{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:09:52Z","timestamp":1773277792817,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.leukres.2010.04.002","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T08:51:11Z","timestamp":1272703871000},"page":"66-72","source":"Crossref","is-referenced-by-count":22,"title":["Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol"],"prefix":"10.1016","volume":"35","author":[{"given":"St\u00e9phanie","family":"Ha\u00efat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zora","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Lapusan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Vekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Corre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dimicoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ollivier","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.04.002_bib1","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","article-title":"Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century","volume":"113","author":"Pulte","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.04.002_bib2","first-page":"809","article-title":"Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial","volume":"89","author":"Labar","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.04.002_bib3","first-page":"1834","article-title":"Dexamethasone versus methyl-prednisolone in induction therapy for adult acute lymphoblastic (ALL) and non-Hodgkin lymphoma (NHL) patients <= 60 yrs old: final results of the Eortc All-4 phase III trial","volume":"106","author":"Labar","year":"2005","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1016\/j.leukres.2010.04.002_bib4","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial","volume":"22","author":"Thomas","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.04.002_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.04.002_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jnci\/djn276","article-title":"Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990\u20132004","volume":"100","author":"Pulte","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2010.04.002_bib7","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V84.5.1603.bloodjournal8451603","article-title":"Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia","volume":"84","author":"Boucheix","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.04.002_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","article-title":"Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials","volume":"21","author":"Boissel","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.04.002_bib9","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1200\/JCO.2008.20.8959","article-title":"Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group","volume":"27","author":"Nachman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.04.002_bib10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.leu.2403538","article-title":"Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands","volume":"18","author":"de Bont","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.04.002_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.20749","article-title":"Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII\/E2993) trials","volume":"48","author":"Ramanujachar","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.leukres.2010.04.002_bib12","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.1954.1954","article-title":"Difference in outcome of adolescents with acute lymphoblastic leukemai (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols [abstract]","volume":"104","author":"Testi","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2010.04.002_bib13","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","article-title":"What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies","volume":"112","author":"Stock","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.04.002_bib14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1200\/JCO.2003.11.116","article-title":"Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimen? Better doctors? Both?","volume":"21","author":"Schiffer","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.04.002_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.04.002_bib16","article-title":"A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphoblastic leukemia [abstract]","volume":"108","author":"De Angelo","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2010.04.002_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2009.07712.x","article-title":"Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen","volume":"146","author":"Storring","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2010.04.002_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V99.3.825","article-title":"Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"99","author":"Lange","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.04.002_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.1998.00818.x","article-title":"Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables","volume":"102","author":"Donadieu","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2010.04.002_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.leu.2404495","article-title":"Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children","volume":"21","author":"Dufourg","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.04.002_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","article-title":"Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia","volume":"345","author":"Chessells","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2010.04.002_bib22","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","article-title":"Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86","volume":"84","author":"Reiter","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.04.002_bib23","first-page":"1226","article-title":"Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Gr*oup Protocol ALL-7 (1988\u20131991)","volume":"94","author":"Kamps","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.04.002_bib24","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1182\/blood-2008-10-184093","article-title":"Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation","volume":"113","author":"Bachanova","year":"2009","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610002043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610002043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T06:17:32Z","timestamp":1591251452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610002043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0145212610002043"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.04.002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}